answer text |
<p>In 2012 the UK proposed that the substance decaBDE should be classified as a substance
of very high concern (SVHC), which would be followed by authorisation procedures to
limit its use. DecaBDE was listed as an SVHC, as proposed by the UK, but the EU decided
not to proceed with authorisation procedures, and took an alternative route of restriction
instead. The restriction was not adopted until 2017. The EU’s decision to opt for
a restriction rather than continuing with the authorisation process resulted in a
delay in regulatory action.</p><p> </p>
|
|